URANIUM ROYALTY CORP (UROY)

CA91702V1013 - Common Stock

3.005  -0.08 (-2.44%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025
Revenue
YoY % growth
13.85M42.706M
208.35%		33.532M
-21.48%
EBITDA
YoY % growth
-5.49M
-2,617.82%		-3.76M
31.51%		7.1M
288.83%		-13.578M
-291.25%
EBIT
YoY % growth
-5.49M
-273.47%		-3.78M
31.15%		7.077M
287.22%		N/A
Operating Margin
N/A-27.29%16.57%N/A
EPS
YoY % growth
N/AN/A
-40.00%		N/A
200.00%		0.07

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 25
EPS
Q2Q % growth		N/A
Revenue
Q2Q % growth		N/A
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		N/A

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
Q3 2023
Q2Q % growth
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth		 12.438M
-10.19%		%
Q4 2023
Q2Q % growth
Q3 2023
Q2Q % growth
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% N/A
RevenueN/A N/A -25.06% N/A